Hagen Brett R — SEC insider filings
SEC reporting owner CIK 1681782. 47 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2021-01-21 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 56 legs across 39 filings — 118,703 shares, $728,144 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 18,011 shares @ $8.18 ($147,258) in Kalaris Therapeutics, Inc., filed 2022-11-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | Chief Accounting Officer | 45 | — | 56 legs · 118,703 sh · $728,144 | 11 |
| InMed Pharmaceuticals Inc. (MTRI) | See Remarks | 2 | — | — | 1 |
Insider filings — Hagen Brett R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 3 | InMed Pharmaceuticals Inc. (MTRI) | Holdings only — no transactions reported | EDGAR |
| 2026-11-12 | 4 | InMed Pharmaceuticals Inc. (MTRI) | Grant/award (A): 171,000 (derivative) @ $0 | EDGAR |
| 2026-03-23 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Sale (S): 1,915 @ $6.72 · Grant/award (A): 60,800 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 50,262 (derivative) @ $0 | EDGAR |
| 2025-03-27 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Sale (S): 907 @ $8.97 | EDGAR |
| 2025-02-24 | 4 | Allovir, Inc. (ALVR) | Sale (S): 96 @ $10.08 | EDGAR |
| 2025-01-27 | 4 | Allovir, Inc. (ALVR) | Sale (S): 32 @ $9.45 · Sale (S): 4 @ $9.94 | EDGAR |
| 2025-01-13 | 4 | Allovir, Inc. (ALVR) | Sale (S): 332 @ $0.44 | EDGAR |
| 2024-11-20 | 4 | Allovir, Inc. (ALVR) | Sale (S): 554 @ $0.55 | EDGAR |
| 2024-11-06 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,655 @ $0.86 | EDGAR |
| 2024-10-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 479 @ $0.78 · Sale (S): 486 @ $0.77 | EDGAR |
| 2024-10-04 | 4 | Allovir, Inc. (ALVR) | Sale (S): 301 @ $0.81 | EDGAR |
| 2024-08-20 | 4 | Allovir, Inc. (ALVR) | Sale (S): 544 @ $0.76 | EDGAR |
| 2024-08-07 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,692 @ $0.73 | EDGAR |
| 2024-07-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 479 @ $0.75 · Sale (S): 481 @ $0.74 | EDGAR |
| 2024-07-03 | 4 | Allovir, Inc. (ALVR) | Sale (S): 304 @ $0.72 | EDGAR |
| 2024-05-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 541 @ $0.75 | EDGAR |
| 2024-05-07 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,597 @ $0.80 | EDGAR |
| 2024-04-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 473 @ $0.75 · Sale (S): 480 @ $0.75 | EDGAR |
| 2024-04-04 | 4 | Allovir, Inc. (ALVR) | Sale (S): 281 @ $0.77 | EDGAR |
| 2024-02-22 | 4 | Allovir, Inc. (ALVR) | Sale (S): 494 @ $0.70 | EDGAR |
| 2024-02-09 | 4 | Allovir, Inc. (ALVR) | Sale (S): 11,150 @ $0.67 | EDGAR |
| 2024-02-06 | 4 | Allovir, Inc. (ALVR) | Sale (S): 5,792 @ $0.67 | EDGAR |
| 2024-01-25 | 4 | Allovir, Inc. (ALVR) | Sale (S): 901 @ $0.67 | EDGAR |
| 2024-01-08 | 4 | Allovir, Inc. (ALVR) | Sale (S): 310 @ $0.64 | EDGAR |
| 2024-01-02 | 4 | Allovir, Inc. (ALVR) | Sale (S): 28,335 @ $0.74 | EDGAR |
| 2023-11-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 403 @ $1.63 | EDGAR |
| 2023-10-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 358 @ $1.58 · Sale (S): 357 @ $1.54 | EDGAR |
| 2023-10-05 | 4 | Allovir, Inc. (ALVR) | Sale (S): 222 @ $1.98 | EDGAR |
| 2023-08-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,653 @ $2.50 | EDGAR |
| 2023-07-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 342 @ $3.56 · Sale (S): 342 @ $3.35 | EDGAR |
| 2023-06-13 | 4 | Allovir, Inc. (ALVR) | Sale (S): 5,045 @ $5.64 | EDGAR |
| 2023-04-21 | 4 | Allovir, Inc. (ALVR) | Sale (S): 348 @ $3.71 · Sale (S): 349 @ $3.63 | EDGAR |
| 2023-02-03 | 4 | Allovir, Inc. (ALVR) | Grant/award (A): 61,250 @ $0 · Grant/award (A): 113,750 (derivative) @ $0 | EDGAR |
| 2023-01-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,557 @ $5.08 · Sale (S): 338 @ $5.14 | EDGAR |
| 2022-11-14 | 4 | Allovir, Inc. (ALVR) | Sale (S): 5,989 @ $8.00 · Sale (S): 18,011 @ $8.18 | EDGAR |
| 2022-10-26 | 4/A | Allovir, Inc. (ALVR) | Sale (S): 345 @ $9.36 | EDGAR |
| 2022-10-24 | 4 | Allovir, Inc. (ALVR) | Sale (S): 345 @ $9.36 · Sale (S): 11,334 @ $8.45 · Sale (S): 2,000 @ $8.13 | EDGAR |
| 2022-08-17 | 4 | Allovir, Inc. (ALVR) | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2022-07-06 | 4 | Allovir, Inc. (ALVR) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0 | EDGAR |
| 2022-04-22 | 4 | Allovir, Inc. (ALVR) | Sale (S): 276 @ $6.68 | EDGAR |
| 2022-04-04 | 4 | Allovir, Inc. (ALVR) | Grant/award (A): 17,442 @ $0 · Grant/award (A): 42,558 (derivative) @ $0 | EDGAR |
| 2022-01-24 | 4 | Allovir, Inc. (ALVR) | Sale (S): 1,563 @ $8.75 | EDGAR |
| 2021-02-23 | 4 | Allovir, Inc. (ALVR) | Sale (S): 800 @ $43.14 | EDGAR |
| 2021-02-19 | 4 | Allovir, Inc. (ALVR) | Sale (S): 200 @ $39.35 · Sale (S): 541 @ $40.39 | EDGAR |
| 2021-02-18 | 4 | Allovir, Inc. (ALVR) | Sale (S): 2,750 @ $41.82 · Sale (S): 300 @ $42.67 · Sale (S): 600 @ $38.56 · Sale (S): 220 @ $39.86 · Sale (S): 1,300 @ $41.17 · Sale (S): 200 @ $41.68 | EDGAR |
| 2021-01-21 | 4 | Allovir, Inc. (ALVR) | Grant/award (A): 17,500 @ $0 · Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681782 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs